TipRanks
Go Ultimate55% OFF

Lakefront Biotherapeutics NV (GLPGN) Earnings Dates, Call Summary & Reports

Earnings Data

Estimated Report Date
Nov 12, 2026
TBA (Not Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
-15.11
Last Year’s EPS
-64.63
Same Quarter Last Year
Analyst Consensus
Moderate Sell
Based on 2 Analysts Ratings

Lakefront Biotherapeutics NV (MX:GLPGN) Earnings, Revenues Date & History

-100.000.00100.00200.00300.00Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.

MX:GLPGN Q2 2026 Earnings Report

Earnings ReportEarnings Call SummaryEarnings AudioSlide Deck
MX:GLPGN Upcoming Earnings

Lakefront Biotherapeutics NV's next earnings date is estimated for November 12, 2026, based on past reporting schedules.

MX:GLPGN Earnings History

MX:GLPGN earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress ReleaseSlidesPlay Transcript
Nov 12, 20262026 (Q3)-15.11--64.63――――
Aug 10, 20262026 (Q2)-14.740.63-33.26101.90% (+33.89)――
May 06, 20262026 (Q1)-17.164.42-49.47108.94% (+53.89)――
Feb 23, 20262025 (Q4)-2.32249.886.084007.27% (+243.80)――
Nov 05, 20252025 (Q3)-8.63-64.63-15.58-314.86% (-49.05)――
Jul 23, 20252025 (Q2)-4.19-33.261.47-2357.14% (-34.73)――
Apr 23, 20252025 (Q1)-2.86-49.477.58-752.78% (-57.05)――
Feb 12, 20252024 (Q4)-10.766.0850.31-87.91% (-44.23)――
Oct 30, 20242024 (Q3)-3.26-15.588.21-289.74% (-23.79)――
Aug 01, 20242024 (Q2)-1.431.471.68-12.50% (-0.21)――

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.

Beat Missed
Show More

FAQ

When does Lakefront Biotherapeutics NV (MX:GLPGN) report earnings?
Lakefront Biotherapeutics NV (MX:GLPGN) is estimated to report earnings on Nov 12, 2026, TBA (Not Confirmed). The date is an estimate based on past reporting schedules and may change.
What is MX:GLPGN EPS forecast?
MX:GLPGN EPS forecast for the fiscal quarter 2026 (Q3) is -15.11.